Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01539759 · ClinicalTrials.gov registry record · NA
Immediate Postplacental Insertion of IUDs at Time of Cesarean Delivery: A Randomized Clinical Trial
A NA study of Cesarean Section and Intrauterine Devices, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
- 1
- Study location
NCT01539759: Completed NA study of Cesarean Section and Intrauterine Devices, sponsored by University of North Carolina, Chapel Hill.
NCT01539759 is a NA study of Cesarean Section and Intrauterine Devices that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 112 participants, below the 162-participant average among 14 other Cesarean Section trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01539759, a NA study of Cesarean Section and Intrauterine Devices, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized controlled trial among women who deliver by cesarean at UNC Women's Hospital and desire an Intrauterine Device (IUD) for contraception postpartum. After consenting, women will be randomized to receive an IUD at time of cesarean delivery or at a postpartum visit 4-8 weeks later. After randomization, subjects will be given a choice of the Mirena® IUD or the Paragard® IUD. Data collection will occur at baseline, delivery, the 4-8 week postpartum visit, and 2 follow-up encounters at 3 and 6 months. We hypothesize that women who receive an IUD at the time of cesarean will be more likely to use an IUD 6 months later than women who plan on receiving an IUD 4-8 weeks after delivery.
Primary Outcome
The use of an IUD at 6 months postpartum is the primary outcome measure
Conditions Studied
Interventions
- DEVICE Immediate Postplacental Placement of an IUD during cesarean delivery
Study Locations (1)
North Carolina
- University of North Carolina, Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2012-03 |
| Est. Completion | 2014-08 |
| Phase | NA |
What the finished NCT01539759 record still lists
NCT01539759 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 162-participant average among 14 other Cesarean Section trials with a reported enrollment target (31% lower).
The record links to 2 conditions, with Cesarean Section appearing as the primary indexed condition, and to 1 intervention - of which Immediate Postplacental Placement of an IUD during cesarean delivery is the first listed.
NCT01539759 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01539759 about?
NCT01539759 is a clinical study titled "Immediate Postplacental Insertion of IUDs at Time of Cesarean Delivery: A Randomized Clinical Trial". This is a randomized controlled trial among women who deliver by cesarean at UNC Women's Hospital and desire an Intrauterine Device (IUD) for contraception postpartum. After consenting, women will be randomized to receive an IUD at time of cesarean delivery or at a postpartum visit 4-8 weeks later. ...
What is the current status of trial NCT01539759?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2012-03. Estimated completion is 2014-08.
What conditions does trial NCT01539759 study?
This clinical trial studies the following conditions: Cesarean Section, Intrauterine Devices.
What interventions are being tested in trial NCT01539759?
The interventions under investigation include: Immediate Postplacental Placement of an IUD during cesarean delivery (DEVICE).
Who is sponsoring clinical trial NCT01539759?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01539759 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cesarean Section
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01539759's enrollment target sits among peer trials
112 7th of 14 higher than 8 of 14 other Cesarean Section trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cesarean Section trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Pain Control
RECRUITING · NA
-
Post-operative Cesarean Trial of Pain Control
RECRUITING · NA
-
A Comparison of Manual vs. Spontaneous Removal of the Placenta at Cesarean Section
COMPLETED · NA
-
The Effects of Music Therapy on Women's Anxiety Before and During Cesarean Delivery
COMPLETED · NA
-
Chlorhexidine Gluconate Versus Povidone Iodine at Cesarean Delivery: a Randomized Controlled Trial
COMPLETED · NA
-
Using the Peanut Exercise Ball to Reduce Cesarean Section Rates: A Randomized Controlled Trial
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia